Budget 2026: Opportunities for clinical research despite budget cuts?

‍

Despite the budget cut in the core budget, Germany continues to invest massively in research. The recently presented draft budget 2026 by Federal Finance Minister Lars Klingbeil sends mixed signals for the research landscape: While the section plan of the Federal Ministry of Research, Technology and Space (BMFTR), at 21.3 billion euros, is one billion lower than 2025 — and somewhat lower than 2024 — there are still strategic investment priorities.

Despite the nominal cut in the core budget, the Federal Government is focusing on strategic compensation: A total of 17.1 billion euros are earmarked for research and development in 2026, supplemented by Germany's High-Tech Agenda with 18 billion euros by 2029. “Research for seriously ill people and people with rare diseases” is being explicitly promoted. The 1,000 heads plus program to attract international scientists is supported with over 600 million euros in this legislative period.

Despite budget consolidation, there are still opportunities for our clients: The focus remains on targeted promotion of medical innovation and evidence-based therapeutic approaches even in difficult times.

‍